-Site-specific changes in modification (p<0.003)
Abstract
The mitochondrial DNA (mtDNA) resides in the vicinity of energy-rich reactions. Thus, chemical modifications of mtDNA might mirror mitochondrial processes and could serve as biomarkers of metabolic processes in the mitochondria. This hypothesis was tested by assessing modifications at 17 different sites in the mtDNA as a function of cell type, oxidative stress and mitochondrial activity. Two mouse mutants with a metabolic phenotype were compared to wild-type (WT) mice: the ogg1 -/-mouse that lacks the 8-oxoguanine DNA glycosylase (OGG1), and the alkbh7 -/-mouse missing the ALKBH7 protein that has been implicated in fatty acid oxidation. It was found that cell type, oxidative stress and mitochondrial complex activity shaped distinct modification patterns in mtDNA, and that OGG1 and ALKBH7 independently modulated these modification patterns. The modifications included ribonucleotides, which also accumulated in mtDNA with age.
Interestingly, this age-dependent accumulation most likely involves DNA repair, as mtDNA from ogg1 -/-mice did not accumulate modifications with age. On the other hand, alkbh7
Introduction
The mtDNA is a circular, multicopy genome of 16.6 kb in mammals and resides in the same organelle that hosts high energy-converting redox reactions in the cell. Reactive metabolites have sufficient energy to modify mtDNA. Previous studies have consistently reported more oxidized base lesions in mtDNA than in nuclear DNA, supporting the assumption that lesions accumulate preferentially in mtDNA [1, 2] . Additionally, genotoxins exposed to cells predominantly target mtDNA as compared to nuclear DNA and indicate that the mtDNA itself is more prone to modifications from environmental stimuli [3] . The increased sensitivity of mtDNA to oxidation has been explained by the absence of histone-dependent organization of DNA in the mitochondria. However, mtDNA forms assemblies with proteins and cardiolipin in chromatin-like structures known as nucleoids [4] . Proteomic analyses with isolated mtDNA-bound fractions from various sources have identified metabolic enzymes, electron transport chain components, transcription factors, replication factors and heat shock/chaperone proteins to this structure [5] . The heterologous arrangement of mtDNA implies that changes on the mtDNA can be sensed by proteins involved in many different metabolic processes-or vice versa that metabolic processes generate modifications in the mtDNA characteristic of the ongoing process.
Emerging results imply that DNA repair has strong implications for metabolism. The OGG1 DNA glycosylase participates in nuclear and mitochondrial base excision repair (BER) and the ogg1 -/-mouse accumulate mtDNA damage, suffers from hyperglycemia, hyperinsulinemia and diet-induced obesity [6, 7] . Another mitochondrial DNA glycosylase, NEIL1, maintains mtDNA and protects against high fat diet-induced metabolic alteration as well [7] . Other mtDNA repair functions like CSB and Ape1 have been associated with metabolic regulations [8, 9] , and together imply that there is a mechanistic link between metabolic activity and (mt)DNA maintenance.
The E.coli AlkB protein repairs methylated DNA bases, while the many mammalian homolog's have different roles in regulating methyl modifications. The ALKBH7 protein resides in the mitochondria and is associated with fatty acid oxidation [10] . Although the molecular activity of ALKBH7 is still unknown, the mouse mutant weighs more and develops obesity when fed on high fat diet, reminiscent of neil1 -/-and ogg1 -/-mice. It was additionally found that the alkbh7 -/-mice exhibited a specific carbohydrate-dependent altered respiration capacity [10] .
Since mtDNA is vulnerable to damage from neighbouring metabolic processes, we hypothesize that it is modified in a manner that reflects the metabolic activity of the organelle.
The assembly of metabolic proteins and mtDNA in the nucleoid might produce a sequencespecific modification of mtDNA. Different tissues have a distinct mitochondrial composition [11] , thus we postulated that the mtDNA modifications would be induced in a tissue specific manner as well as correlating with other metabolism-influencing factors like age, oxidative stress and genotype. The ogg1 -/-and alkbh7 -/-mutants represent interesting models in this respect.
We previously identified modification frequency in mtDNA [12] at a level that exceeds previous estimates (~5x10 -4 per nt) of the major lesion 8-oxoguanine [6, 13] . The modifications are detected by the ability to inhibit DNA restriction enzyme digestion. The method has been used to quantify epigenetic marks of DNA, and although mitochondrial epigenetics is still enigmatic [14] , the method can be used to characterize DNA integrity in general. The identity of underlying mtDNA modifications can be explored by nucleic acidmodifying enzymes.
Here, we have used a combination of molecular biology methods and statistical analyses to evaluate possible correlation between mitochondrial processes and mtDNA. Our findings unravel new sides of mtDNA and its continuous processes that revitalize the role of mtDNA repair. DNA isolation from cells and purified mitochondria was performed similarly except that RNAlater was omitted.
Materials and methods

RNA isolation
Total RNA was isolated using RNeasy Mini Kit (Qiagen), according to the manufacturer's description. cDNA was synthesised from isolated total RNA using QuantiTect Reverse Transcription Kit (Qiagen). Gene expression was measured using all the same primer sets as for mtDNA modification analysis.
mtDNA modification analysis
The qPCR method to characterize mtDNA modifications was established previously [16] and is based on the ability of DNA damage to inhibit Taq α I restriction enzymes cleavage. Here, the method is expanded to capture 17 restriction enzyme sites, in three mitochondrial genes. 
mtDNA mutation analysis
The mtDNA mutation frequency was determined in the T1 and T2 sites, as described previously [17] .
Oligonucleotides
The primers used are supplied in Table 2 , and were purchased from Eurofins Genomics.
Modified oligonucleotides (containing modified cytosines or ribonucleotides) were from
Eurofins Genomics and are provided in Table 3 . Annealing of complementary oligonucleotides was carried out in 1X UltraPure SSC buffer (Thermo Fisher Scientific) in a thermal cycler with the following conditions: 95 ºC for 5 minutes followed by a temperature decrease of 0.1ºC pr. second until 20ºC was reached.
Statistical analyses
Students T-test was used to check for statistical significance between sample groups using a Bonferroni corrected p-value for multiple testing (p ≤ 0.003). Correlation analysis was carried out in SPSS using Spearman correlation analysis. Principle component analyses were performed to characterize hierarchal groups. All groups were included in the calculations to provide similar component reference, after where selected groups were presented separately to allow better comparisons. The majority of the variation was found in the first component (>90%). between sites were less variable, except for the T1 and A2/A3 sites. The cumulative modification levels (sum of modifications in all sites) were similar in MEF mtDNA and heart mtDNA (reference), demonstrating that the difference cannot be ascribed to DNA damage load. To further evaluate sensitivity to batch variations, we determined the relative modification level in a site (site modification divided by the sum of modifications in all sites). The results demonstrate that heart and MEF mtDNA have site-specific modifications that can be used to distinguish heart from MEFs.
Results
Cell-and condition
We then compared the modification pattern in reference mtDNA with mtDNA from two other post-mitotic tissues: liver and brain. Relative to reference mtDNA, the H1 and H4 sites in brain mtDNA were less modified, while the H6 was more modified. Liver mtDNA was more modified in the sites M1, H2, M2, T2, H3 and M3, but less in the H3 and H4 sites (p<0.003). Table 4 provides an overview of site difference. It became apparent that 3 sites (A1, A3 and H5) are similar in all tissues while the remaining sites display tissue specific patterns. For instance, the modification of the Cox1 site H4 appears to be specific to heart tissue as the site contribution is altered in all other situations.
When MEF mtDNA was compared with reference mtDNA, the H1, M1, H3, A2 and H4 were largely distinct ( Figure 1F ). mtDNA from embryonic stem cells (ES) were included to test the idea that differentiation lineage might contribute to the modification pattern. In general, the ES mtDNA displayed a modification pattern that mimicked MEF mtDNA except for some selected sites, suggesting that lineage is a less likely determinant for mtDNA modification than perhaps proliferation capacity. Oxidative stress has previously shown to modify mtDNA [12] . Given the impact of tissue type on modification pattern, we re-evaluated the effect of hydrogen peroxide treatment on modifications in all 17 sites ( Figure 1F ). Hydrogen peroxide induced a different mtDNA modification in sites H1, T1, M2, A2, H4, M4, A3, H5 and M5.
Importantly, 8 sites did not respond to peroxide treatment, and the sites A1 and A2 became even less modified upon treatment, demonstrating that mtDNA modification level is not generally increased by peroxide. Dimension reduction analyses of the modifications throughout the 17 sites unravelled that MEF mtDNA clustered closer to tissue mtDNA than to ES mtDNA ( Figure 6D ). Interestingly, mtDNA from hydrogen peroxide-treated MEFs was shifted in the ES mtDNA direction (upwards in Figure 6D ), suggesting that ES mtDNA shares features of oxidized intracellular conditions.
To investigate the impact of mitochondrial enzymes on site-specific modifications, brain, liver and heart mtDNA were analysed from young mice with defective ALKBH7 and OGG1
functions (Figure 2A and B, respectively). ALKBH7 has previously been shown to have altered mitochondrial function [10] , and the OGG1 protein is essential for removal of 8-oxoguanine from mtDNA [6] . Genotype-specific effects were observed in alkbh7 -/-brain mtDNA and in ogg1 -/-mtDNA (all tissues) (Compare Figure 2A and 2B with Figure 1E , and see Table 4 ). For instance, for brain H4 and T1 were differently modified in both alkbbh7
-/-and ogg1 -/-brain mtDNAs as compared to WT mtDNA.
Age influences mtDNA modifications in an OGG1-and ALKBH7-dependent manner
The content of mitochondrial 8-oxoguanine increases with age in rodents [18] implying that increases in mtDNA modification levels are expected in 10-11 months old animals, termed adults, compared to the young mice. Figure 3A shows the average change in the modification level in the 17 sites of adult heart mtDNA compared to young heart mtDNA. The alterations that reached statistical significance are shown in Figure 3B . Included in Figure 3B are additionally the corresponding age-dependent changes in brain and liver mtDNA from WT Figure S3) . Surprisingly, the mtDNA from ogg1 -/-mice did not
show any age effect in any of the sites in any tissue ( Figure 3D , Table 4 ). In support of the site-specific effect of age, the cumulative mtDNA modification level for all 17 sites was higher in the adult WT and alkbh7 -/-mice, but not in adult ogg1 -/-mice, compared to young mice (Supplementary Figure S1 ). An overview of all the 17 site modifications with age for each genotype is provided in Supplementary Figure S2. 3.3. mtDNA modifications accumulate in a mitochondrial metabolism-dependent manner
The impact of genotype and cell type is indicative of intramitochondrial metabolic processes being responsible for establishing the mtDNA modification pattern. To test whether metabolic alterations could rapidly establish a distinct mtDNA modification profile, isolated mitochondria were energized in vitro with complex I (pyruvate+malate: PM) or complex II substrates (Succinate: Succ) supplied with either ADP or menadione; a redox cycler known to generate superoxide anion. Mitochondria were isolated from heart and liver from WT, alkbh7 -/-and ogg1 -/-mice. As shown in Figure 4A and B, WT mtDNA became modified in a tissuespecific manner upon energization with different substrates. Young WT mitochondria in general responded stronger to energization. While complex I and complex II/ADP activation induced distinct effects on liver mtDNA, heart mitochondria responded more synchronous to the different complex activations ( Figure 4B ).
mtDNA from alkbh7 -/-hearts displayed a much more heterogeneous modification profile than corresponding WT mtDNA. Upon complex II/ADP activation the principle component 1 for liver mtDNA responded stronger than during complex I/ADP activation. ALBH7-deficient heart mtDNA did not display similar divergence (Figure 4C and D) .
In general, mtDNA from ogg1 -/-liver and heart were highly different, and clustered as two separate groups, where principle component 1 was mainly responsible for the separation.
Importantly, compared to nontreated mitochondria, energization exerted in general different effects on mtDNA modification as compared to WT and alkbh7 -/-mtDNA modification ( Figure 4E and F).
In summary, the energizations therefore affected the mtDNA in a genotype-and tissue (cell type) specific manner. Importantly, while mtDNA from MEF undergoing peroxide treatment clustered upwards in the PCA plot (principle component 2; Figure 6D and to some extent also RNA-DNA heteroduplex, while AluI was efficiently inhibited by both single stranded DNA and RNA ( Figure 5B ). As shown in Figure 5C , HpaII was inhibited by all combinations of modifications and strictly required double stranded DNA substrate. In contrast, the isoform MspI tolerated single stranded substrate when not modified, as well as single methylated duplex DNA ( Figure 5D ). These results agree with the above findings ( Figure 1 and 2 ) that the estimated level of modifications in the TaqI sites is indicative of a strong restriction enzyme activity towards various modifications. In view of the sensitivity profiles ( Figure 5B-D) , ongoing transcription could be responsible for the modification signal.
However, the levels of the three transcripts (12S, Nd1 and Cox1) did not correlate with the modification signals ( Figure 5E ).
The impact of ribonucleotides was investigated more closely. DNA from young male heart (reference mtDNA) was treated with RNaseI f to remove ribonucleotides prior to analyses.
This resulted in a dramatic reduction in the modification level ( Figure 6A ) and suggested that RNA indeed contributes to the modification signal. However, when the relative modification profile was determined (as in Figure 1C ), it became evident that although RNA contributed to the level of modification, it appeared not to dictate the distribution of modifications along the 17 sites ( Figure 6B ). We then evaluated the effect of RNase treatment on MEF mtDNA 3.5. Nuclear DNA modification is different from mtDNA modification
We previously found that damage to nuclear DNA was induced in a site-specific manner [12] .
In order to investigate if the modification dependence discovered for mtDNA is valid for nuclear DNA as well, a sequence in the Gapdh gene containing all recognition sites closely positioned were analysed (Figure 7 ). In the four selected sites, there was no indication of increased modification of age in nuclear DNA from heart ( Figure 7A ). When comparing brain and liver from young and adult mice, the effect of age was absent except for an increased signal produced by the HpaII enzyme originating from the adult female cohort. Principle component analysis indicated relative clustering of the heart and brain nuclear DNA, while nuclear DNA from liver and ES/MEF cells differed ( Figure 7C ). Pretreatment with RNase to remove RNA did not alter the principal components, indicating that RNA does not contribute to modification pattern of nuclear DNA ( Figure 7D ).
mtDNA modifications do not influence mtDNA integrity
In nuclear DNA, DNA damage causes nucleotide misincorporation by replicating polymerases with the chance of manifesting into mutations. Likewise, mtDNA modifications might in turn drive mtDNA mutagenesis that ultimately results in altered mitochondrial function and thereby produce the metabolic phenotypes of the animal models tested here. To test the possibility that mtDNA mutations underlie some of the mtDNA modifications, the frequencies of mutated TaqI restriction enzyme sites were determined. TaqI is resistant to single stranded DNA and ribonucleotide ( Figure 5B ) and have successfully been used to quantify the frequency of mutations in mtDNA [17, 19] . The mtDNA mutation frequencies in the T1 site was previously found to be lower than in the T2 site, as well as differing approximately two-fold between 1 and 18 months of age [17] . This was confirmed here ( Figure 8A ). Interestingly, mtDNA mutation frequency appeared to increase dramatically in the adult alkbh7 -/-mice. However, there was no correlation between mtDNA mutation frequency and mtDNA modification levels ( Figure 8B ). In contrast, the mtDNA modification levels in the T1 site correlated with those in the T2 (r=0.92, p<0.001) ( Figure 8C ) and accordingly, mutation frequencies in the two sites correlated significantly (r=0.83, p<0.001) ( Figure 8D ). The situation was similar for the specific genotypes as well. Thus, modification of mtDNA does not impact mtDNA mutagenesis and therefore is unlikely to influence the mutation frequency of the mitochondrial genome.
Discussion
In the current study, we show that mtDNA rapidly responds to metabolic processes. Different tissues and genotypes, as well as age were characterized by distinct patterns of mtDNA modifications. It was found that the mitochondrial OGG1 and ALKBH7 proteins contributed to mtDNA modifications. Importantly, OGG1 strongly mediates the age-mediated modification of mtDNA.
The conditions that were addressed in this study were chosen because they were either known to alter mitochondrial function, as exemplified by altered biochemical complex activity with age [20] , the increased mitochondrial respiration capacity in alkbh7 -/-liver [10] , metabolic phenotype of the ogg1 -/-and alkbh7 -/-mice [7, 10] , or because they influence mtDNA integrity like tissue-specific copy number and mtDNA repair capacity [21, 22] . One implication from our finding is that tissue specificity, mtDNA repair capacity and mitochondrial function correlate with mtDNA modifications, which in turn mirrors the mitochondrial identity. In this paper, 17 different sites representing less than 0.1% of the total mtDNA were investigated, suggesting that modifications can occur everywhere in the mtDNA, and thus be a very important feature of the mtDNA biology. The molecular explanation is possibly linked to the organization of mtDNA into tight assemblies with metabolic proteins, proteins from fatty acid oxidation and members of oxidative decarboxylation complexes that are classified as nucleoid members [5, 23] . Importantly, many metabolic complexes (as e.g. pyruvate dehydrogenase) generate superoxide that can exceed the ETC-mediated superoxide production from complex I [24, 25] . The mitochondrial nucleoid wraps up mtDNA in a metabolism-dependent manner [26] , and studies of various cells and tissues [5, [27] [28] [29] imply that the nucleoid has a tissue-specific composition that modifies the mtDNA in a mitochondrion-specific manner.
The impact of OGG1 in forming the mtDNA modification profile combined with the metabolic profile of OGG1-deficient animals infers that the modification of mtDNA is not only a secondary feature of ongoing metabolism, but may also serve to regulate metabolic processes. Classically, functional impact of mtDNA modifications is attributed to mitochondrial epigenetics, and although there are several reports of CpG-and non-CpG methylation of mtDNA, many of the applied methods are associated with false signals [14] .
However, although some mtDNA modifications can be ascribed to cytosine methylation, the modifications identified in recognition sites of cytosine methylation-resistant restriction enzymes (Table 4) suggest that other types of molecular signals serve epigenetic features. It is interesting to note that aconitase, a ROS-sensitive/sensor intramitochondrially is stabilized by mitochondrial OGG1 in an repair-independent manner [30] .
Here, alkbh7 -/-mice were included with the purpose to investigate potential effect on mtDNA modification level. Although ALKBH7 paralogues have DNA repair activities, the mitochondrial ALKBH7 does not necessarily act on mtDNA. Initial characterizations implied a role of ALKBH7 in fatty acid oxidation and metabolic regulation. In view of ALKBH7's role in energized mitochondria, it is possible that metabolic alterations formed the mtDNA modifications characteristic of the mutant's mitochondrial activity. While modifications in the mtDNA from the ogg1 -/-was resistant to age, the alkbh7 -/-mtDNA appears in general to be more responsive (Table 4) , perhaps an indication of the higher mitochondrial respiration capacity in the mutant [10] .
The principal component analyses enabled a closer identification of the sites whose contributions determined the size of component 1, which represented more than 90% of the variations. To distinguish between tissues, the contributions from sites A1, A2 and A3 were typically shifted to negative values (from close to +1). E.g. Succinate energization exerted a different effect on the component, mainly due to negative contribution from the sites H1, T1-H3, H4, M4 and H6 (for liver mitochondria). In heart mitochondria, a similar pattern was apparent. Thus, in summary, while AluI sites seem to determine tissue and genotype specificity by the first component, they appeared to have lower impact on shaping mtDNA modifications during energization of isolated mitochondria. On the other hand, HpaII sensitivity appears to be more discriminative for the energization. HpaII is known to be sensitive to sequence contexts, suboptimal reaction conditions, in addition to methylation [14] .
Correlation analyses allowed us to conclude that mtDNA modifications that are characteristic of metabolism, as well as that they do not influence mtDNA mutation frequency. This is supported by the normal mtDNA mutation frequency in the mtDNA repair double mutant [20] . Biochemical studies have indicated that mtDNA mutation frequency is merely a side effect of (sequence-dependent) misincorporation by DNA pol γ, rather than as being caused by mispairing of accumulating, premutagenic base lesions in the mDNA [31, 32] . The obvious question is then why the cell harbours a mtDNA repair system if it is not to protect against mutagenesis. Ectopic overexpression of OGG1 protects cells against elevated oxidative stress, support normal neuronal biogenesis and secures mitochondrial maturation during stem cell differentiation [33] [34] [35] . In view of the present data, it cannot be ruled out that the survival effect is due to metabolic regulation rather than cytotoxic effects of unrepaired mtDNA lesions. Emerging results imply that the cellular role of mtDNA repair is closer associated to metabolic regulation than survival [7, 36] .
Supplemental data
Supplemental data include Figure S1 -S3. The mtDNA modifications in the same sites as in Figure 1 were analyzed in liver, brain and heart of ogg1 -/-and alkbh7 -/-mice. (A) Relative site modification was calculated for the indicated tissues from young ALKBH7-deficient mice and presented as average deviation from reference ( Figure 1C) , with SD (n= 4). (B) Relative site modification was calculated and presented similarly for the indicated tissue from young OGG1-deficient mice, with SD. Color codes: brain (black), heart (blue) and liver (grey) mtDNA, (n= 3). 
